Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.2747 USD
−5.00 M USD
0.00 USD
5.32 M
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PTIX is 0.6200 USD — it has increased by 2.17% in the past 24 hours. Watch Protagenic Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Protagenic Therapeutics, Inc. stocks are traded under the ticker PTIX.
PTIX stock has fallen by −3.57% compared to the previous week, the month change is a −10.59% fall, over the last year Protagenic Therapeutics, Inc. has showed a −22.50% decrease.
PTIX reached its all-time high on Dec 28, 1998 with the price of 584,539,200.0000 USD, and its all-time low was 0.4900 USD and was reached on Oct 11, 2024. View more price dynamics on PTIX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PTIX stock is 5.80% volatile and has beta coefficient of −0.18. Track Protagenic Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Protagenic Therapeutics, Inc. there?
Today Protagenic Therapeutics, Inc. has the market capitalization of 4.13 M, it has decreased by −1.63% over the last week.
Yes, you can track Protagenic Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Protagenic Therapeutics, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PTIX net income for the last quarter is −640.78 K USD, while the quarter before that showed −1.61 M USD of net income which accounts for 60.11% change. Track more Protagenic Therapeutics, Inc. financial stats to get the full picture.
No, PTIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 3.00 employees. See our rating of the largest employees — is Protagenic Therapeutics, Inc. on this list?
Like other stocks, PTIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Protagenic Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Protagenic Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Protagenic Therapeutics, Inc. stock shows the sell signal. See more of Protagenic Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.